Application of a New Serum Assay for Type I Collagen Cross-Linked N-Telopeptides: Assessment of Diurnal Changes in Bone Turnover With and Without Alendronate Treatment

Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis

Uri Liberman, Stuart Weiss, Johann Bröll et al. · New England Journal of Medicine · 1995 · 2.3K citations

Medicine, Endocrinology, Bone Metabolism +14

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis

Patrick Garnero, Elisabeth Sornay‐Rendu, M. C. Chapuy et al. · Journal of Bone and Mineral Research · 1996 · 1K citations

Medicine, Endocrinology, Geriatric Medicine +17

Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.

Patrick Garnero, W J Shih, Évelyne Gineyts et al. · The Journal of Clinical Endocrinology & Metabolism · 1994 · 682 citations · Full text

Medicine, Pharmacology, Bone Metabolism +16

A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine

Dennis A. Hanson, Mary Ann Weis, Anne‐Marie Bollen et al. · Journal of Bone and Mineral Research · 1992 · 669 citations

Medicine, Biochemistry, Molecular Biology +17

Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation

Juha Risteli, Inkeri Elomaa, S. Niemi et al. · Clinical Chemistry · 1993 · 637 citations

Medicine, Pathology, Bone Metabolism +14